Showing results (111-120 of 543) with videos related to
Sort By:
Pageof 55
Journal of the American College of Cardiology|June 17, 1998
Heparin-induced thrombocytopeniaD B Brieger, K H Mak, K Kottke-Marchant, et al.Journal of the American College of Cardiology|November 1, 1987
Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) trialE J Topol, R M Califf, D J Kereiakes, et al.The American Journal of Cardiology|October 15, 1990
Quantitative angiographic comparison of the immediate success of coronary angioplasty, coronary atherectomy and endoluminal stentingD W Muller, S G Ellis, D L Debowey, et al.JAMA|March 10, 1999
Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for StentingS R Steinhubl, W A Tan, J M Foody, et al.Journal of the American College of Cardiology|April 1, 1997
Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trialsD L Dries, Y D Rosenberg, M A Waclawiw, et al.Thrombosis and Haemostasis|December 30, 1998
In vitro efficacy of platelet glycoprotein IIb/IIIa antagonist in blocking platelet function in plasma of patients with heparin-induced thrombocytopeniaK H Mak, K Kottke-Marchant, L M Brooks, et al.Journal of the American College of Cardiology|March 18, 1999
The relationship between periprocedural myocardial infarction and subsequent target vessel revascularization following percutaneous coronary revascularization: insights from the EPIC trial. Evaluation of IIb/IIIa platelet receptor antagonist 7E3 in Preventing Ischemic ComplicationsC R Narins, D P Miller, R M Califf, et al.Clinical Cardiology|May 1, 1996
Restenosis--an open fileM Gottsauner-Wolf, D J Moliterno, A M Lincoff, et al.Clinical Genetics|May 7, 2014
Influence of individual differences in disease perception on consumer response to direct-to-consumer genomic testingD L Boeldt, N J Schork, E J Topol, et al.Circulation|November 11, 1999
Relation between lesion characteristics and risk with percutaneous intervention in the stent and glycoprotein IIb/IIIa era: An analysis of results from 10,907 lesions and proposal for new classification schemeS G Ellis, V Guetta, D Miller, et al.Pageof 55